Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Technology Segment
1.2.2. Delivery Method Segment
1.2.3. Application Segment
1.2.4. Mode Segment
1.2.5. End Use Segment
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Market Model
1.7.1. Commodity Flow Analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Middle East Genome Editing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Widespread adoption of CRISPR technologies
3.2.1.2. National genome programs boosting regional research
3.2.2. Market restraint analysis
3.2.2.1. Challenges concerning clinical translation
3.2.2.2. Regulatory, scientific, and ethical challenges regarding the use of genetically modified products
3.3. Middle East Genome Editing Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. Middle East Genome Editing Market: Technology Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Middle East Genome Editing Market Technology Movement Analysis
4.3. Middle East Genome Editing Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
4.4. (CRISPR)/Cas9
4.4.1. (CRISPR)/Cas9 market estimates and forecasts 2021 to 2033 (USD Million)
4.5. TALENs/MegaTALs
4.5.1. TALENs/MegaTALs market estimates and forecasts 2021 to 2033 (USD Million)
4.6. ZFN
4.6.1. ZFN market estimates and forecasts 2021 to 2033 (USD Million)
4.7. Meganuclease
4.7.1. Meganuclease market estimates and forecasts 2021 to 2033 (USD Million)
4.8. Others
4.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Middle East Genome Editing Market: Delivery Method Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Middle East Genome Editing Market Delivery Method Movement Analysis
5.3. Middle East Genome Editing Market Size & Trend Analysis, by Delivery Method, 2021 to 2033 (USD Million)
5.4. Ex Vivo
5.4.1. Ex vivo market estimates and forecasts 2021 to 2033 (USD Million)
5.5. in Vivo
5.5.1. in vivo market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Middle East Genome Editing Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Middle East Genome Editing Market Application Movement Analysis
6.3. Middle East Genome Editing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Genetic Engineering
6.4.1. Genetic engineering market estimates and forecasts 2021 to 2033 (USD Million)
6.4.2. Cell Line Engineering
6.4.2.1. Cell line engineering market estimates and forecasts 2021 to 2033 (USD Million)
6.4.3. Animal Genetic Engineering
6.4.3.1. Animal genetic engineering market estimates and forecasts 2021 to 2033 (USD Million)
6.4.4. Plant Genetic Engineering
6.4.4.1. Plant genetic engineering market estimates and forecasts 2021 to 2033 (USD Million)
6.4.5. Others
6.4.5.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Clinical Applications
6.5.1. Clinical applications market estimates and forecasts 2021 to 2033 (USD Million)
6.5.2. Diagnostics Development
6.5.2.1. Diagnostics development market estimates and forecasts 2021 to 2033 (USD Million)
6.5.3. Therapy Development
6.5.3.1. Therapy development market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Middle East Genome Editing Market: Mode Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Middle East Genome Editing Market Mode Movement Analysis
7.3. Middle East Genome Editing Market Size & Trend Analysis, by Mode, 2021 to 2033 (USD Million)
7.4. Contract
7.4.1. Contract market estimates and forecasts 2021 to 2033 (USD Million)
7.5. in-house
7.5.1. in-house market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 8. Middle East Genome Editing Market: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Middle East Genome Editing Market End Use Movement Analysis
8.3. Middle East Genome Editing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
8.4. Biotechnology and Pharmaceutical Companies
8.4.1. Biotechnology and pharmaceutical companies market estimates and forecasts 2021 to 2033 (USD Million)
8.5. Academic and Government Research Institutes
8.5.1. Academic and government research institutes market estimates and forecasts 2021 to 2033 (USD Million)
8.6. Contract Research Organizations
8.6.1. Contract research organizations market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 9. Middle East Genome Editing Market: Country Estimates & Trend Analysis
9.1. Country Market Share Analysis, 2024 & 2033
9.2. Country Market Dashboard
9.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
9.4. Middle East
9.4.1. Saudi Arabia
9.4.1.1. Key country dynamics
9.4.1.2. Competitive scenario
9.4.1.3. Regulatory landscape
9.4.1.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
9.4.2. UAE
9.4.2.1. Key country dynamics
9.4.2.2. Competitive scenario
9.4.2.3. Regulatory landscape
9.4.2.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
9.4.3. Kuwait
9.4.3.1. Key country dynamics
9.4.3.2. Competitive scenario
9.4.3.3. Regulatory landscape
9.4.3.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
9.4.4. Qatar
9.4.4.1. Key country dynamics
9.4.4.2. Competitive scenario
9.4.4.3. Regulatory landscape
9.4.4.4. Qatar market estimates and forecasts 2021 to 2033 (USD Million)
9.4.5. Oman
9.4.5.1. Key country dynamics
9.4.5.2. Competitive scenario
9.4.5.3. Regulatory landscape
9.4.5.4. Oman market estimates and forecasts 2021 to 2033 (USD Million)
9.4.6. Rest of Middle East
9.4.6.1. Key country dynamics
9.4.6.2. Competitive scenario
9.4.6.3. Regulatory landscape
9.4.6.4. Rest of Middle East market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company/Competition Categorization
10.2. Strategy Mapping
10.3. Company Market Position Analysis, 2024
10.4. Company Profiles/Listing
10.4.1. Merck KGaA
10.4.1.1. Company overview
10.4.1.2. Financial performance
10.4.1.3. Product benchmarking
10.4.1.4. Strategic initiatives
10.4.2. Takara Bio Inc.
10.4.2.1. Company overview
10.4.2.2. Financial performance
10.4.2.3. Product benchmarking
10.4.2.4. Strategic initiatives
10.4.3. Revvity, Inc.
10.4.3.1. Company overview
10.4.3.2. Financial performance
10.4.3.3. Product benchmarking
10.4.3.4. Strategic initiatives
10.4.4. Danaher Corporation
10.4.4.1. Company overview
10.4.4.2. Financial performance
10.4.4.3. Product benchmarking
10.4.4.4. Strategic initiatives
10.4.5. GenScript
10.4.5.1. Company overview
10.4.5.2. Financial performance
10.4.5.3. Product benchmarking
10.4.5.4. Strategic initiatives
10.4.6. New England Biolabs
10.4.6.1. Company overview
10.4.6.2. Financial performance
10.4.6.3. Product benchmarking
10.4.6.4. Strategic initiatives
10.4.7. Charles River Laboratories
10.4.7.1. Company overview
10.4.7.2. Financial performance
10.4.7.3. Product benchmarking
10.4.7.4. Strategic initiatives
10.4.8. Eurofins Scientific
10.4.8.1. Company overview
10.4.8.2. Financial performance
10.4.8.3. Product benchmarking
10.4.8.4. Strategic initiatives
10.4.9. Lonza
10.4.9.1. Company overview
10.4.9.2. Financial performance
10.4.9.3. Product benchmarking
10.4.9.4. Strategic initiatives
10.4.10. Thermo Fisher Scientific, Inc.
10.4.10.1. Company overview
10.4.10.2. Financial performance
10.4.10.3. Product benchmarking
10.4.10.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Regulatory Framework
Table 4 Middle East Genome editing Market, by country, 2021-2033 (USD Million)
Table 5 Middle East Genome editing Market, by technology, 2021-2033 (USD Million)
Table 6 Middle East Genome editing Market, by delivery method, 2021-2033 (USD Million)
Table 7 Middle East Genome editing Market, by applications, 2021-2033 (USD Million)
Table 8 Middle East Genome editing Market, by mode, 2021-2033 (USD Million)
Table 9 Middle East Genome editing Market, by end use, 2021-2033 (USD Million)
Table 10 Saudi Arabia Genome editing Market, by technology, 2021-2033 (USD Million)
Table 11 Saudi Arabia Genome editing Market, by delivery method, 2021-2033 (USD Million)
Table 12 Saudi Arabia Genome editing Market, by applications, 2021-2033 (USD Million)
Table 13 Saudi Arabia Genome editing Market, by mode, 2021-2033 (USD Million)
Table 14 Saudi Arabia Genome editing Market, by end use, 2021-2033 (USD Million)
Table 15 UAE Genome editing Market, by technology, 2021-2033 (USD Million)
Table 16 UAE Genome editing Market, by delivery method, 2021-2033 (USD Million)
Table 17 UAE Genome editing Market, by applications, 2021-2033 (USD Million)
Table 18 UAE Genome editing Market, by mode, 2021-2033 (USD Million)
Table 19 UAE Genome editing Market, by end use, 2021-2033 (USD Million)
Table 20 Kuwait Genome editing Market, by technology, 2021-2033 (USD Million)
Table 21 Kuwait Genome editing Market, by delivery method, 2021-2033 (USD Million)
Table 22 Kuwait Genome editing Market, by applications, 2021-2033 (USD Million)
Table 23 Kuwait Genome editing Market, by mode, 2021-2033 (USD Million)
Table 24 Kuwait Genome editing Market, by end use, 2021-2033 (USD Million)
Table 25 Qatar Genome editing Market, by technology, 2021-2033 (USD Million)
Table 26 Qatar Genome editing Market, by delivery method, 2021-2033 (USD Million)
Table 27 Qatar Genome editing Market, by applications, 2021-2033 (USD Million)
Table 28 Qatar Genome editing Market, by mode, 2021-2033 (USD Million)
Table 29 Qatar Genome editing Market, by end use, 2021-2033 (USD Million)
Table 30 Oman Genome editing Market, by technology, 2021-2033 (USD Million)
Table 31 Oman Genome editing Market, by delivery method, 2021-2033 (USD Million)
Table 32 Oman Genome editing Market, by applications, 2021-2033 (USD Million)
Table 33 Oman Genome editing Market, by mode, 2021-2033 (USD Million)
Table 34 Oman Genome editing Market, by end use, 2021-2033 (USD Million)
Table 35 Rest of Middle East Genome editing Market, by technology, 2021-2033 (USD Million)
Table 36 Rest of Middle East Genome editing Market, by delivery method, 2021-2033 (USD Million)
Table 37 Rest of Middle East Genome editing Market, by applications, 2021-2033 (USD Million)
Table 38 Rest of Middle East Genome editing Market, by mode, 2021-2033 (USD Million)
Table 39 Rest of Middle East Genome editing Market, by end use, 2021-2033 (USD Million)
List of Figures
Figure 1 Middle East genome editing market segmentation
Figure 2 Information procurement
Figure 3 Data analysis models
Figure 4 Market formulation and validation
Figure 5 Data validating & publishing
Figure 6 Market research process
Figure 7 Information procurement
Figure 8 Primary research
Figure 9 Market snapshot
Figure 10 Segment snapshot
Figure 11 Competitive landscape snapshot
Figure 12 Middle East genome editing market: Technology outlook key takeaways
Figure 13 Middle East genome editing market: Technology movement analysis
Figure 14 Middle East CRISPR/Cas9 market, 2021-2033 (USD Million)
Figure 15 Middle East ZFN market, 2021-2033 (USD Million)
Figure 16 Middle East meganuclease market, 2021-2033 (USD Million)
Figure 17 Middle East others market, 2021-2033 (USD Million)
Figure 18 Middle East genome editing market: Delivery Method outlook and key takeaways
Figure 19 Middle East genome editing market: Delivery Method movement analysis
Figure 20 Middle East ex vivo market, 2021-2033 (USD Million)
Figure 21 Middle East in vivo market, 2021-2033 (USD Million)
Figure 22 Middle East genome editing market: Application outlook and key takeaways
Figure 23 Middle East genome editing market: Application movement analysis
Figure 24 Middle East genetic engineering market, 2021-2033 (USD Million)
Figure 25 Middle East cell line engineering market, 2021-2033 (USD Million)
Figure 26 Middle East animal genetic engineering market, 2021-2033 (USD Million)
Figure 27 Middle East plant genetic engineering market, 2021-2033 (USD Million)
Figure 28 Middle East others market, 2021-2033 (USD Million)
Figure 29 Middle East clinical applications market, 2021-2033 (USD Million)
Figure 30 Middle East therapy development market, 2021-2033 (USD Million)
Figure 31 Middle East diagnostics development market, 2021-2033 (USD Million)
Figure 32 Middle East genome editing market: Mode outlook and key takeaways
Figure 33 Middle East genome editing market: Mode movement analysis
Figure 34 Middle East contract market, 2021-2033 (USD Million)
Figure 35 Middle East in-house market, 2021-2033 (USD Million)
Figure 36 Middle East genome editing market: End use outlook and key takeaways
Figure 37 Middle East genome editing market: End use movement analysis
Figure 38 Middle East biotechnology & pharmaceutical companies market, 2021-2033 (USD Million)
Figure 39 Middle East academic & research institutes market, 2021-2033 (USD Million)
Figure 40 Middle East contract research organizations market, 2021-2033 (USD Million)
Figure 41 Middle East genome editing market revenue, by country, 2022 & 2033 (USD Million)
Figure 42 Country marketplace outlook, 2024 & 2033 (USD Million)
Figure 43 Country marketplace: Key takeaways
Figure 44 Key country dynamics
Figure 45 Saudi Arabia genome editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 46 Key country dynamics
Figure 47 UAE genome editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 48 Key country dynamics
Figure 49 Kuwait genome editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 50 Key Country Dynamics
Figure 51 Qatar genome editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 52 Key country dynamics
Figure 53 Oman genome editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 54 Key country dynamics
Figure 55 Rest of Middle East genome editing market estimates and forecasts, 2021-2033 (USD Million)
Figure 56 Market participant categorization
Figure 57 Strategic framework
